Quanterix Corporation Net Income (Loss) Available to Common Stockholders, Basic
Quanterix Corporation (QTRX) reported Net Income (Loss) Available to Common Stockholders, Basic of -$40.80 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2020-03-13
- Quanterix Corporation net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was -$9.33M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$7.66M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$7.34M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was -$7.20M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for fiscal 2019 was -$40.80M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for fiscal 2018 was -$31.54M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for fiscal 2017 was -$31.19M.
- Quanterix Corporation net income (loss) available to common stockholders, basic for fiscal 2016 was -$27.62M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$40.80M 10-K · filed 2020-03-13 | |||
| 2018-12-31 | -$9.33M 10-K · filed 2019-03-18 | -$16.99M derived: sum of 2 quarters · filed 2019-03-18 | -$24.33M derived: sum of 3 quarters · filed 2019-03-18 | -$31.54M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$7.66M 10-K · filed 2019-03-18 | -$15.00M derived: sum of 2 quarters · filed 2019-03-18 | -$22.20M 10-Q · filed 2018-11-07 | -$30.40M derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-06-30 | -$7.34M 10-K · filed 2019-03-18 | -$14.54M 10-Q · filed 2018-08-10 | -$22.75M derived: sum of 3 quarters · filed 2019-03-18 | -$30.49M derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-03-31 | -$7.20M 10-K · filed 2019-03-18 | -$15.40M derived: sum of 2 quarters · filed 2019-03-18 | -$23.15M derived: sum of 3 quarters · filed 2019-03-18 | -$30.89M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-12-31 | -$8.20M 10-K · filed 2019-03-18 | -$15.94M derived: sum of 2 quarters · filed 2019-03-18 | -$23.69M derived: sum of 3 quarters · filed 2019-03-18 | -$31.19M 10-K · filed 2020-03-13 |
| 2017-09-30 | -$7.74M 10-K · filed 2019-03-18 | -$15.49M derived: sum of 2 quarters · filed 2019-03-18 | -$22.99M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$7.75M 10-K · filed 2019-03-18 | -$15.24M 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | -$7.50M 10-K · filed 2019-03-18 | |||
| 2016-12-31 | -$27.62M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |